Project Grant 2208230
Award Date
5/15/22
Completion Date
4/30/23
Dollars Obligated
$256K
Federal Agency
National Science Foundation
Awardee
Encapsulate Inc. (JKQNFNJWF175)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Farmington, CT 06032, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Cerflux Inc. aims to develop a personalized cancer treatment screening platform. The project will establish guidelines for handling solid tumor biopsy samples, generate 3D bioprinted tumor models for validation, and demonstrate the platform's ability to match patients with the most effective cancer treatments before treatment begins. This innovative approach has the...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award to Vivosphere LLC for $275,000 will support the development of a novel tissue-engineered platform for cancer modeling and drug screening. The project aims to create a more physiologically relevant, high-throughput screening model to improve the translation rate between preclinical and clinical testing of anti-cancer drug candidates. The proposed technology utilizes a 3D hydrogel...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Redpoint Oncology, Inc. aims to develop and validate a novel platform for targeted cancer therapies. The project seeks to create "guided missile-like" cancer treatments that can selectively target and destroy therapy-resistant cancer cells. Key research objectives include designing new payload candidates, testing their anti-cancer efficacy and selectivity,...
This National Science Foundation Project Grant of $606,649 will support the development of an engineered cyber-physical system combining advanced biological models and artificial intelligence methods to enable precision medicine for cancer treatment. Awarded under the Computer and Information Science and Engineering program, the funding will be used by Brigham and Women's Hospital and its parent organization Partners Healthcare System from October 2022 to September 2025. Specifically, the...
This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection to...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program (CFDA 47.084) provides $275,000 to Dcan Biosciences LLC to develop an advanced microfluidic system for cancer diagnosis and monitoring. The system aims to isolate and assess circulating tumor cells (CTCs) and CTC clusters (CTCCs) from patient blood samples to enable highly sensitive and accurate liquid biopsies. Key objectives include designing a hybrid microfluidic device for...
This Project Grant award from the National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) program (CFDA 47.070) provides $275,956 to the University of Massachusetts Lowell to develop an engineered cyber-physical system that combines advanced biological models with state-of-the-art artificial intelligence (AI) methods. The goal is to enable accurate, real-time prediction of patient responses to anti-cancer therapies, advancing the precision medicine paradigm...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award provides $305,000 in funding to Sostos Inc., a minority-owned, woman-owned small business, to develop a cloud-based software platform for identifying multi-omics biomarkers critical for guiding non-small cell lung cancer treatment decisions that can be applied to broad patient populations. The proposed technology leverages advanced artificial intelligence and predictive Boolean...
The National Science Foundation (NSF) awarded a $275,000 SBIR Phase I grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Om Therapeutics Inc. in La Jolla, CA. The goal of this project is to enable the discovery of new medicines at an unprecedented rate by empowering researchers to launch drug discovery programs quickly and cost-effectively. The innovation involves the ability to screen billions of unique small molecules against the entire human proteome in a...
This $305,000 federal Project Grant was awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on April 15, 2025. The funding supports the development of a microchip-based technology by Cellecho, Inc. that leverages sound waves and electric fields to manipulate cells and sequentially deliver customizable combinations of genetic coding molecules. The broader goal is to make advanced cell engineering more accessible and...